PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
To Prospectus Dated December 17, 1996, Registration No. 333-08269
As Supplemented to Date
$100,000,000
PHYMATRIX CORP.
6-3/4% Convertible Subordinated Debentures due 2003
and
Shares of Common Stock, Par Value $.01 Per Share,
Issuable Upon Conversion Thereof
This Prospectus Supplement (the "Supplement") relates to the resale by BT
Securities Corporation ("BT Securities") of up to $1,325,000 aggregate principal
amount of 6-3/4% Convertible Subordinated Debentures due 2003 (the "Debentures")
of PhyMatrix Corp., a Delaware corporation (the "Company"), originally issued in
private placements consummated on June 26, 1996 (the "Debt Offering"), pursuant
to PhyMatrix Corp.'s Registration Statement on Form S-1 (No. 333-08269) (the
"Registration Statement"). This Supplement should be read in conjunction with
the Prospectus dated December 17, 1996, as supplemented to date (the
"Prospectus"), to be delivered with this Supplement. All capitalized terms used
but not defined in this Supplement shall have the meanings given them in the
Prospectus.
Based on information provided to the Company, the aggregate principal
amount of the Debentures that are currently beneficially owned by BT Securities
is $1,325,000, of which $1,325,000 may be sold at this time pursuant to the
Prospectus as supplemented hereby. Additional information concerning the Selling
Securityholders (including BT Securities) may be set forth from time to time in
additional supplements to the Prospectus. The total outstanding aggregate
principal amount of the Debentures is $100,000,000.
The closing price of the Company's Common Stock as reported on The Nasdaq
National Market on January 14, 1997 was $16.75 per share.
The Debentures will be subordinated to all existing and future Senior
Indebtedness of the Company. At October 31, 1996, Senior Indebtedness was
approximately $7.3 million. The Indenture contains no limitations on the
incurrence of additional indebtedness or other liabilities by the Company.
The Debentures are neither listed on a national securities exchange nor
quoted on an automated quotation system. However, the Debentures are eligible
for trading in the Private Offerings, Resales and Trading through Automated
Linkages ("PORTAL") Market. Debentures sold pursuant to the Registration
Statement will no longer be eligible for trading in the PORTAL Market.
The date of this Prospectus Supplement is January 14, 1997.
